Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by investclubon Dec 09, 2019 7:44pm

155 Views

Post# 30437817

McGill

If McGill was the second Canadian site at the end of July then I would think they must have treated somewhere between 3 to 6 patients by now and would also guess London has 1 or 2 under their belt . Anyone willing to consider where the 4th Canadian site will be a friend suggested Alberta which makes sense if Theralase wants a diverse population then Alberta would be an excellent choice.

Bullboard Posts

Unique Battery Metals opportunity in Quebec